FDA Issues Emergency Use Authorization for Remdesivir
Remdesivir can be administered intravenously to treat COVID-19 patients with severe disease
April 2020 Briefing – Pharmacy
Here are what the editors at HealthDay consider to be the most important developments in Pharmacy for April 2020. This roundup includes the latest...
April 2020 Briefing – Pain Management
Here are what the editors at HealthDay consider to be the most important developments in Pain Management for April 2020. This roundup includes the...
April 2020 Briefing – Geriatrics
Here are what the editors at HealthDay consider to be the most important developments in Geriatrics for April 2020. This roundup includes the latest...
April 2020 Briefing – Cosmetic Surgery
Here are what the editors at HealthDay consider to be the most important developments in Cosmetic Surgery for April 2020. This roundup includes the...
April 2020 Briefing – Anesthesiology
Here are what the editors at HealthDay consider to be the most important developments in Anesthesiology for April 2020. This roundup includes the latest...
April 2020 Briefing – Radiology
Here are what the editors at HealthDay consider to be the most important developments in Radiology for April 2020. This roundup includes the latest...
April 2020 Briefing – Pathology
Here are what the editors at HealthDay consider to be the most important developments in Pathology for April 2020. This roundup includes the latest...
April 2020 Briefing – Nephrology
Here are what the editors at HealthDay consider to be the most important developments in Nephrology for April 2020. This roundup includes the latest...
April 2020 Briefing – Otolaryngology
Here are what the editors at HealthDay consider to be the most important developments in Otolaryngology for April 2020. This roundup includes the latest...
